Table 3.
Comparison of mitochondrial outcomes in fibroblasts from younger and older adults with and without FXTAS
| Age (y) | Mitochondrial outcomes | Reference | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| Complex I | Complex II | Complex IV | Complex V | Citrate synthase | ||
| 28 ± 2 (asymptomatic) | 23%* | N.D. | 51%* | 64% | 164%* | This study |
| 71 ± 2 (asymptomatic) | 100% | 142% | 34%* | 71% | 74% | [8] |
| 68 ± 3 (FXTAS-affected) | 75% | 68% | 56%* | 38%* | 100% | [8] |
p < 0.05 vs. age- and sex-matched controls. Activities are expressed as nmol x (min x mg protein)−1, normalized by citrate synthase and expressed as % of control values (age- and sex-matched), except citrate synthase. N.D. Not determined.